(3beta,7beta,15alpha,25R)-3,7,15-Trihydroxy-11,23-dioxolanost-8-en-26-oic acid(CAS: 103773-62-2)

(3beta,7beta,15alpha,25R)-3,7,15-Trihydroxy-11,23-dioxolanost-8-en-26-oic acid is a white, crystalline solid with a molecular weight of approximately 488.5 g/mol. It has a low solubility in water and moderate solubility in organic solvents. The compound is relatively stable under normal conditions but can react with strong acids or bases. It is not flammable and has a melting point around 190°C.

(3beta,7beta,15alpha,25R)-3,7,15-Trihydroxy-11,23-dioxolanost-8-en-26-oic acid is synthesized through a multi-step process involving the hydrogenation of a 26-ene precursor, followed by oxidation and hydroxylation steps. Common catalysts include palladium on carbon and other transition metals. The overall yield is around 70-80%, and the process is conducted under mild conditions to maintain the integrity of the compound.

(3beta,7beta,15alpha,25R)-3,7,15-Trihydroxy-11,23-dioxolanost-8-en-26-oic acid is primarily used in the pharmaceutical industry as an intermediate for the synthesis of various bioactive compounds. It is also explored in the polymer industry for developing new materials with specific properties. Additionally, it has potential applications in the production of sensors and semiconductors.

When handling (3beta,7beta,15alpha,25R)-3,7,15-Trihydroxy-11,23-dioxolanost-8-en-26-oic acid, it is important to use appropriate personal protective equipment (PPE) such as gloves, goggles, and a lab coat. Work should be conducted in a fume hood to minimize inhalation risks. Spills should be cleaned up immediately using appropriate absorbents. Always refer to the Safety Data Sheet (SDS) for specific handling and disposal instructions.